Company profile for InSitu Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

InSitu Biologics is an emerging biotech company focused on development of a multi-phase prolonged release drug delivery platform for localized treatment of pain, cancer, and infection. We use disruptive technology to address unmet needs in the pain management and drug delivery markets.InSitu Biologics is currently in the investigational pre-clinical stage. Products are not yet for sale in any geography.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3510 Hopkins Place N., Building 4, Oakdale, MN 55128
Telephone
Telephone
(651) 337 – 4799
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Mayo, InSitu pen prolonged-release cancer co-development pact
Mayo, InSitu pen prolonged-release cancer co-development pact

03 Jan 2023

// Nick Paul Taylor FIERCE PHARMA

https://www.fiercepharma.com/pharma/mayo-spreads-support-insitu-prolonged-release-cancer-drug-co-development-pact

Nick Paul Taylor FIERCE PHARMA
03 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty